Sequential First-Pass Metabolism of Nortilidine: The Active Metabolite of the Synthetic Opioid Drug Tilidine-Reference-Cited by-同舟云学术

Sequential First-Pass Metabolism of Nortilidine: The Active Metabolite of the Synthetic Opioid Drug Tilidine

Published:2002-11 Issue:11 Volume:42 Page:1257-1261
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Hajda Jacek Piotr,Jähnchen Eberhard,Øie Svein,Trenk Dietmar

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference8 articles.

1. The opiate-like action of tilidine is mediated by metabolites;Schulz;Naunyn-Schmiedeberg's Arch Pharmacol,1978

2. Metabolism of ethyl DL-trans-2-dimethylamino-1-phenylcyclohex-3-ene-trans-1-carboxylate hydrochloride: 1. Mass spectroscopic structural elucidation of metabolites I and II and their determination in various biological fluids;Vollmer;Arzneim-Forsch (Drug Res),1974

3. Human pharmacokinetics of the new potent analgesic DL-trans-2-di-methylamino-1-phenyl-cyclohex-3-en-trans-1-carboxylic acid ethyl ester hydrochloride: 1. Blood level and excretion with urine and feces after single oral administration of 14C-labeled substance;Vollmer;Arzneim-Forsch (DrugRes),1970

4. Pharmacokinetics of tilidine and metabolites in man;Vollmer;Arzneim-Forsch (Drug Res),1989

5. Primary, secondary, and tertiary metabolite kinetics;St-Pierre;J Pharmacokinet Biopharm,1988

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analgetika;Arzneimitteltherapie in der Palliativmedizin;2022

2. Tilidine and dipyrone (metamizole) in cold pressor pain: A pooled analysis of efficacy, tolerability, and safety in healthy volunteers;Clinical and Translational Science;2021-05-31

3. Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach;Frontiers in Psychiatry;2021-02-09

4. Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1;Journal of Medicinal Chemistry;2019-10-09

5. Analgetika;Arzneimitteltherapie in der Palliativmedizin;2018